352 related articles for article (PubMed ID: 20545619)
21. Quantitative evaluation of the in vitro effect and interactions of active fractions in Yaotongning-based formulae on prostaglandin E₂ production.
Ni LJ; Xu XL; Zhang LG; Shi WZ
J Ethnopharmacol; 2014 Jul; 154(3):807-17. PubMed ID: 24853621
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of traditional Chinese medicine targeting the cellular apoptotic pathway.
Xu H; Zhao X; Liu X; Xu P; Zhang K; Lin X
Drug Des Devel Ther; 2015; 9():2735-44. PubMed ID: 26056434
[TBL] [Abstract][Full Text] [Related]
23. Targeting Tumor Immunosuppressive Microenvironment for the Prevention of Hepatic Cancer: Applications of Traditional Chinese Medicines in Targeted Delivery.
Zhang LY; Zhang JG; Yang X; Cai MH; Zhang CW; Hu ZM
Curr Top Med Chem; 2020; 20(30):2789-2800. PubMed ID: 33076809
[TBL] [Abstract][Full Text] [Related]
24. Chinese medicines with sedative-hypnotic effects and their active components.
Shi MM; Piao JH; Xu XL; Zhu L; Yang L; Lin FL; Chen J; Jiang JG
Sleep Med Rev; 2016 Oct; 29():108-18. PubMed ID: 26866454
[TBL] [Abstract][Full Text] [Related]
25. Anticancer carbazole alkaloids and coumarins from Clausena plants: A review.
Huang L; Feng ZL; Wang YT; Lin LG
Chin J Nat Med; 2017 Dec; 15(12):881-888. PubMed ID: 29329644
[TBL] [Abstract][Full Text] [Related]
26. Chemoinformatics approaches for traditional Chinese medicine research and case application in anticancer drug discovery.
Li XJ; Kong DX; Zhang HY
Curr Drug Discov Technol; 2010 Mar; 7(1):22-31. PubMed ID: 20156137
[TBL] [Abstract][Full Text] [Related]
27. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
Kostova I
Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
[No Abstract] [Full Text] [Related]
28. Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
Youns M; Hoheisel JD; Efferth T
Curr Drug Discov Technol; 2010 Mar; 7(1):37-45. PubMed ID: 20156142
[TBL] [Abstract][Full Text] [Related]
29. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
[TBL] [Abstract][Full Text] [Related]
30. Potential new inorganic antitumour agents from combining the anticancer traditional Chinese medicine (TCM) liriodenine with metal ions, and DNA binding studies.
Chen ZF; Liu YC; Liu LM; Wang HS; Qin SH; Wang BL; Bian HD; Yang B; Fun HK; Liu HG; Liang H; Orvig C
Dalton Trans; 2009 Jan; (2):262-72. PubMed ID: 19089006
[TBL] [Abstract][Full Text] [Related]
31. Research Advances in the Intervention of Inflammation and Cancer by Active Ingredients of Traditional Chinese Medicine.
Huang Y; Cai T; Xia X; Cai Y; Wu XY
J Pharm Pharm Sci; 2016; 19(1):114-26. PubMed ID: 27096696
[TBL] [Abstract][Full Text] [Related]
32. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases.
Lu Y; Ma X; Chang X; Liang Z; Lv L; Shan M; Lu Q; Wen Z; Gust R; Liu W
Chem Soc Rev; 2022 Jul; 51(13):5518-5556. PubMed ID: 35699475
[TBL] [Abstract][Full Text] [Related]
33. Ethnopharmacological and bioactivity guided investigation of five TCM anticancer herbs.
Meng QX; Roubin RH; Hanrahan JR
J Ethnopharmacol; 2013 Jun; 148(1):229-38. PubMed ID: 23623820
[TBL] [Abstract][Full Text] [Related]
34. Anticancer metallotherapeutics in preclinical development.
Kaluderović GN; Paschke R
Curr Med Chem; 2011; 18(31):4738-52. PubMed ID: 21919843
[TBL] [Abstract][Full Text] [Related]
35. Recent development of transition metal complexes with in vivo antitumor activity.
Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
[TBL] [Abstract][Full Text] [Related]
36. New applications of old metal-binding drugs in the treatment of human cancer.
Schmitt SM; Frezza M; Dou QP
Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
[TBL] [Abstract][Full Text] [Related]
37. Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review.
Zhai B; Zhang N; Han X; Li Q; Zhang M; Chen X; Li G; Zhang R; Chen P; Wang W; Li C; Xiang Y; Liu S; Duan T; Lou J; Xie T; Sui X
Biomed Pharmacother; 2019 Jun; 114():108812. PubMed ID: 30965237
[TBL] [Abstract][Full Text] [Related]
38. [Advance of studies on bioactivity of flavonoid-metal complexes].
Liu Y; He X; Zuo H; Zhang Q; Li Z; Shi L
Zhongguo Zhong Yao Za Zhi; 2012 Jul; 37(13):1901-4. PubMed ID: 23019867
[TBL] [Abstract][Full Text] [Related]
39. Traditional Chinese medicine (TCM) as a source of new anticancer drugs.
Yao CL; Zhang JQ; Li JY; Wei WL; Wu SF; Guo DA
Nat Prod Rep; 2021 Sep; 38(9):1618-1633. PubMed ID: 33511969
[TBL] [Abstract][Full Text] [Related]
40. Copper, gold and silver compounds as potential new anti-tumor metallodrugs.
Tan SJ; Yan YK; Lee PP; Lim KH
Future Med Chem; 2010 Oct; 2(10):1591-608. PubMed ID: 21426151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
